Despite assurances from President Donald Trump’s administration in January that the coronavirus outbreak in the country is under control, new COVID cases in the country continued to rise. In fact, the U.S. is now the leading country in terms of the number of confirmed infections after surpassing China and Italy last week.
The recent development did not escape Hillary Clinton who has been consistently critical of President Donald Trump’s handling of the coronavirus pandemic. On Friday, the former Secretary of State took to Twitter mocking her former campaign rival and linking his “America First” slogan to the current top spot the U.S. occupies in terms of COVID-19 cases, according to Newsweek.
“He did promise ‘America First,’” Clinton tweeted. She also shared a New York Times article that reported how the U.S. became the country hardest hit by the coronavirus pandemic on Thursday.
There are now more than 150 thousand people confirmed to be infected with the virus in the U.S. There are now more than 2,800 reported deaths due to the virus.
Trump used the “America First” slogan during his 2016 campaign against Clinton. “We assembled here today are issuing a new decree to be heard in every city, in every foreign capital, and in every hall of power,” Trump said in his January 2017 inaugural address. “From this day forward, a new vision will govern our land. From this moment on, it's going to be America First.”
Clinton also criticized Trump for contradicting medical experts. “A month ago, Trump said: ‘It’s going to disappear. One day, it’s like a miracle, it will disappear,’” she wrote on a different post. “Yesterday, he said: ‘I don’t believe you need 40,000 or 30,000 ventilators.’ What will it take to get @realdonaldtrump to listen to experts instead of his own hunches?”
The former Secretary of State also criticized Trump’s response to the pandemic. “The Trump administration was told in January that coronavirus was likely to become a pandemic,” she wrote in a tweet last week. “They refused to act for fear of spooking the markets, losing weeks of time to prepare that we won't get back.”


FDA Weighs Safety Standards for Psychedelic Therapies
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Zelenskiy Says Trump’s Support for Russia Is ‘Painful’
Container Ship Sinks in Strait of Hormuz as Iran Attacks Escalate
U.S. Issues Cuba Health Alert as Illnesses Rise
Syndax Stock Drops 15% After Axatilimab Trial Failure
Flavio Bolsonaro Backs Brazil’s 40-Hour Workweek Reform Ahead of Runoff
US Justice Department Drops Prosecution of Ex-CIA Analyst Sue Mi Terry
China Resumes US Soybean Purchases After Trump-Xi Summit
US Condemns China Sanctions on Taiwan Allies Belize and Paraguay
US Recalls Nicaragua Envoy After Ambassador Rejection
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Jordan Bardella Antisemitism Allegations Threaten Le Pen’s Campaign
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
MI5 Warns of Rising Iran, Russia Threats and AI Bioweapon Risks 



